Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 408

1.

Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights.

Anestis A, Zoi I, Papavassiliou AG, Karamouzis MV.

Molecules. 2020 Jan 15;25(2). pii: E358. doi: 10.3390/molecules25020358. Review.

2.

Orexin-A Exerts Equivocal Role in Atherosclerosis Process Depending on the Duration of Exposure: In Vitro Study.

Nasiri Ansari N, Spentza F, Dimitriadis GK, Daskalopoulou A, Karapanagioti A, Siasos G, Lianidou E, Papavassiliou AG, Kassi E, Randeva HS.

Nutrients. 2019 Dec 24;12(1). pii: E53. doi: 10.3390/nu12010053.

3.

PIWI family proteins as prognostic markers in cancer: a systematic review and meta-analysis.

Mentis AA, Dardiotis E, Romas NA, Papavassiliou AG.

Cell Mol Life Sci. 2019 Dec 9. doi: 10.1007/s00018-019-03403-y. [Epub ahead of print] Review.

PMID:
31814070
4.

Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas.

Zoi I, Karamouzis MV, Xingi E, Sarantis P, Thomaidou D, Lembessis P, Theocharis S, Papavassiliou AG.

Breast Cancer Res. 2019 Dec 3;21(1):132. doi: 10.1186/s13058-019-1226-9.

5.

Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment.

Piperi C, Papavassiliou KA, Papavassiliou AG.

Cells. 2019 Nov 6;8(11). pii: E1398. doi: 10.3390/cells8111398. Review.

6.

Insights in the immunobiology of glioblastoma.

Strepkos D, Markouli M, Klonou A, Piperi C, Papavassiliou AG.

J Mol Med (Berl). 2020 Jan;98(1):1-10. doi: 10.1007/s00109-019-01835-4. Epub 2019 Oct 24. Review.

PMID:
31650201
7.

Osteoprotegerin and Osteopontin Serum Levels are Associated with Vascular Function and Inflammation in Coronary Artery Disease Patients.

Maniatis K, Siasos G, Oikonomou E, Vavuranakis M, Zaromytidou M, Mourouzis K, Paraskevopoulos T, Charalambous G, Papavassiliou AG, Tousoulis D.

Curr Vasc Pharmacol. 2019 Oct 21. doi: 10.2174/1570161117666191022095246. [Epub ahead of print]

PMID:
31642412
8.

The predictive role for ST2 in patients with acute coronary syndromes and heart failure.

Tsigkou V, Siasos G, Bletsa E, Panoilia ME, Papastavrou A, Kokosias G, Oikonomou E, Papageorgiou N, Zaromitidou M, Marinos G, Vavuranakis M, Stefanadis C, Papavassiliou AG, Tousoulis D.

Curr Med Chem. 2019 Oct 16. doi: 10.2174/0929867326666191016121630. [Epub ahead of print]

PMID:
31622195
9.

Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer.

Koustas E, Sarantis P, Theoharis S, Saetta AA, Chatziandreou I, Kyriakopoulou G, Giannopoulou I, Michelli M, Schizas D, Papavassiliou AG, Karamouzis MV.

Am J Clin Oncol. 2019 Oct;42(10):767-776. doi: 10.1097/COC.0000000000000592.

10.

Coronary artery disease and endothelial dysfunction: Novel diagnostic and therapeutic approaches.

Oikonomou E, Siasos G, Tsigkou V, Bletsa E, Panoilia ME, Oikonomou IN, Sinanidis I, Spinou M, Papastavrou A, Kokosias G, Zaromitidou M, Stampouloglou P, Spartalis M, Vavuranakis M, Stefanadis C, Papavassiliou AG, Tousoulis D.

Curr Med Chem. 2019 Aug 29. doi: 10.2174/0929867326666190830103219. [Epub ahead of print]

PMID:
31470773
11.

Regulation of matrix metalloproteinase-1 by Filifactor alocis in human gingival and monocytic cells.

Nokhbehsaim M, Nogueira AVB, Damanaki A, Dalagiorgou G, Eick S, Adamopoulos C, Piperi C, Basdra EK, Papavassiliou AG, Deschner J.

Clin Oral Investig. 2019 Aug 23. doi: 10.1007/s00784-019-03062-0. [Epub ahead of print]

PMID:
31444694
12.

Circulating plasminogen activator inhibitor-1 activity: a biomarker for resectable non-small cell lung cancer?

Sotiropoulos GP, Kotopouli M, Karampela I, Christodoulatos GS, Antonakos G, Marinou I, Vogiatzakis E, Lekka A, Papavassiliou AG, Dalamaga M.

J BUON. 2019 May-Jun;24(3):943-954.

13.

Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice.

Dimitriadis GK, Nasiri-Ansari N, Agrogiannis G, Kostakis ID, Randeva MS, Nikiteas N, Patel VH, Kaltsas G, Papavassiliou AG, Randeva HS, Kassi E.

Mol Cell Endocrinol. 2019 Aug 20;494:110487. doi: 10.1016/j.mce.2019.110487. Epub 2019 Jun 10.

PMID:
31195080
14.

Polycystins and Mechanotransduction in Human Disease.

Gargalionis AN, Basdra EK, Papavassiliou AG.

Int J Mol Sci. 2019 May 2;20(9). pii: E2182. doi: 10.3390/ijms20092182. Review.

15.

The Interplay of Autophagy and Tumor Microenvironment in Colorectal Cancer-Ways of Enhancing Immunotherapy Action.

Koustas E, Sarantis P, Kyriakopoulou G, Papavassiliou AG, Karamouzis MV.

Cancers (Basel). 2019 Apr 14;11(4). pii: E533. doi: 10.3390/cancers11040533. Review.

16.

Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system.

Delimitsou A, Fostira F, Kalfakakou D, Apostolou P, Konstantopoulou I, Kroupis C, Papavassiliou AG, Kleibl Z, Stratikos E, Voutsinas GE, Yannoukakos D.

Hum Mutat. 2019 May;40(5):631-648. doi: 10.1002/humu.23728. Epub 2019 Mar 9.

PMID:
30851065
17.

Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer.

Anestis A, Sarantis P, Theocharis S, Zoi I, Tryfonopoulos D, Korogiannos A, Koumarianou A, Xingi E, Thomaidou D, Kontos M, Papavassiliou AG, Karamouzis MV.

J Cancer Res Clin Oncol. 2019 May;145(5):1221-1233. doi: 10.1007/s00432-019-02872-9. Epub 2019 Feb 25.

PMID:
30805773
18.

Gene-Specific Intron Retention Serves as Molecular Signature that Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients.

Giannopoulou AF, Konstantakou EG, Velentzas AD, Avgeris SN, Avgeris M, Papandreou NC, Zoi I, Filippa V, Katarachia S, Lampidonis AD, Prombona A, Syntichaki P, Piperi C, Basdra EK, Iconomidou V, Papadavid E, Anastasiadou E, Papassideri IS, Papavassiliou AG, Voutsinas GE, Scorilas A, Stravopodis DJ.

Int J Mol Sci. 2019 Feb 21;20(4). pii: E937. doi: 10.3390/ijms20040937.

19.

Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword.

Mentis AA, Boziki M, Grigoriadis N, Papavassiliou AG.

Cell Mol Life Sci. 2019 Jul;76(13):2477-2486. doi: 10.1007/s00018-019-03044-1. Epub 2019 Feb 19.

PMID:
30783683
20.

What can preoperative blood tests tell us about colorectal cancer?

Kostakis ID, Vaiopoulos AG, Garoufalia Z, Papavassiliou AG, Kykalos S, Kouraklis G, Tsourouflis G.

J BUON. 2018 Dec;23(7):84-95.

21.

Impact of advanced glycation end products (AGEs) signaling in coronary artery disease.

Kosmopoulos M, Drekolias D, Zavras PD, Piperi C, Papavassiliou AG.

Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):611-619. doi: 10.1016/j.bbadis.2019.01.006. Epub 2019 Jan 3. Review.

PMID:
30611860
22.

Polycystins in Colorectal Cancer.

Gargalionis AN, Basdra EK, Papavassiliou AG.

Int J Mol Sci. 2018 Dec 28;20(1). pii: E104. doi: 10.3390/ijms20010104. Review.

23.

Upgraded role of autophagy in colorectal carcinomas.

Koustas E, Sarantis P, Papavassiliou AG, Karamouzis MV.

World J Gastrointest Oncol. 2018 Nov 15;10(11):367-369. doi: 10.4251/wjgo.v10.i11.367.

24.

Polycystins in disease mechanobiology.

Gargalionis AN, Basdra EK, Papavassiliou AG.

J Cell Biochem. 2018 Nov 21. doi: 10.1002/jcb.28127. [Epub ahead of print]

PMID:
30461048
25.

Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer.

Sotiropoulos GP, Dalamaga M, Antonakos G, Marinou I, Vogiatzakis E, Kotopouli M, Karampela I, Christodoulatos GS, Lekka A, Papavassiliou AG.

Lung Cancer. 2018 Nov;125:291-299. doi: 10.1016/j.lungcan.2018.10.010. Epub 2018 Oct 10.

PMID:
30429035
26.

The role of autophagy in the treatment of BRAF mutant colorectal carcinomas differs based on microsatellite instability status.

Koustas E, Papavassiliou AG, Karamouzis MV.

PLoS One. 2018 Nov 14;13(11):e0207227. doi: 10.1371/journal.pone.0207227. eCollection 2018.

27.

Redox and NF-κB signaling in osteoarthritis.

Lepetsos P, Papavassiliou KA, Papavassiliou AG.

Free Radic Biol Med. 2019 Feb 20;132:90-100. doi: 10.1016/j.freeradbiomed.2018.09.025. Epub 2018 Sep 17. Review.

PMID:
30236789
28.

Correcting "insertion-deletion mutations" in medical terminology.

Mentis AA, Papavassiliou AG.

J Cell Mol Med. 2018 Dec;22(12):6408-6409. doi: 10.1111/jcmm.13875. Epub 2018 Sep 6. No abstract available.

29.

Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis.

Gargalionis AN, Malakou LS, Adamopoulos C, Piperi C, Theohari I, Nokhbehsaim M, Deschner J, Kokkalis G, Korkolopoulou P, Papadavid E, Papavassiliou AG, Basdra EK.

Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3468-3476. doi: 10.1016/j.bbadis.2018.07.036. Epub 2018 Aug 2.

30.

Mitochondria and cardiovascular diseases-from pathophysiology to treatment.

Siasos G, Tsigkou V, Kosmopoulos M, Theodosiadis D, Simantiris S, Tagkou NM, Tsimpiktsioglou A, Stampouloglou PK, Oikonomou E, Mourouzis K, Philippou A, Vavuranakis M, Stefanadis C, Tousoulis D, Papavassiliou AG.

Ann Transl Med. 2018 Jun;6(12):256. doi: 10.21037/atm.2018.06.21. Review.

31.

Chromatin remodeling defects in pediatric brain tumors.

Klonou A, Spiliotakopoulou D, Themistocleous MS, Piperi C, Papavassiliou AG.

Ann Transl Med. 2018 Jun;6(12):248. doi: 10.21037/atm.2018.04.08. Review.

32.

Molecular mechanisms of mechanotransduction in psoriasis.

Malakou LS, Gargalionis AN, Piperi C, Papadavid E, Papavassiliou AG, Basdra EK.

Ann Transl Med. 2018 Jun;6(12):245. doi: 10.21037/atm.2018.04.09. Review.

33.

Molecular medicine in the translational research era.

Piperi C, Papavassiliou AG.

Ann Transl Med. 2018 Jun;6(12):239. doi: 10.21037/atm.2018.06.22. No abstract available.

34.

Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.

Nasiri-Ansari Ν, Dimitriadis GK, Agrogiannis G, Perrea D, Kostakis ID, Kaltsas G, Papavassiliou AG, Randeva HS, Kassi E.

Cardiovasc Diabetol. 2018 Jul 26;17(1):106. doi: 10.1186/s12933-018-0749-1.

35.

Combination of checkpoint inhibitors with other agents as a strategy to improve anti-cancer effect - a glimpse to the future.

Karamouzis MV, Papavassiliou AG.

Expert Opin Investig Drugs. 2018 Jul;27(7):569-572. doi: 10.1080/13543784.2018.1494724. Epub 2018 Jul 6.

PMID:
29958097
36.

Osteonectin as a screening marker for pancreatic cancer: A prospective study.

Papapanagiotou A, Sgourakis G, Karkoulias K, Raptis D, Parkin E, Brotzakis P, Panchal S, Papavassiliou AG.

J Int Med Res. 2018 Jul;46(7):2769-2779. doi: 10.1177/0300060518772413. Epub 2018 May 13.

37.

Impact of Aldehyde Dehydrogenase Activity on Gliomas.

Vasilogiannakopoulou T, Piperi C, Papavassiliou AG.

Trends Pharmacol Sci. 2018 Jul;39(7):605-609. doi: 10.1016/j.tips.2018.04.001. Epub 2018 May 1. Review.

PMID:
29728268
38.

High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches.

Angelopoulou E, Piperi C, Papavassiliou AG.

J Neurochem. 2018 Aug;146(3):211-218. doi: 10.1111/jnc.14450. Epub 2018 Jul 3. Review.

39.

The Impact of Omega 3 Fatty Acids in Atherosclerosis and Arterial Stiffness: An Overview of their Actions.

Verveniotis A, Siasos G, Oikonomou E, Tsigkou V, Papageorgiou N, Zaromitidou M, Psaltopoulou T, Marinos G, Deftereos S, Vavuranakis M, Stefanadis C, Papavassiliou AG, Tousoulis D.

Curr Pharm Des. 2018;24(17):1865-1872. doi: 10.2174/1381612824666180321095022. Review.

PMID:
29564974
40.

Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.

Mihailidou C, Papakotoulas P, Papavassiliou AG, Karamouzis MV.

Oncotarget. 2017 Dec 8;9(12):10360-10374. doi: 10.18632/oncotarget.23164. eCollection 2018 Feb 13.

41.

Potential Prediction of Acute Biliary Pancreatitis Outcome on Admission.

Papapanagiotou A, Sgourakis G, Peristeraki S, Raptis D, Karkoulias K, Tezas S, Patel P, Papavassiliou AG.

Pancreas. 2018 Apr;47(4):454-458. doi: 10.1097/MPA.0000000000001026.

PMID:
29517633
42.

Tumor mechanosensing and its therapeutic potential.

Gargalionis AN, Basdra EK, Papavassiliou AG.

J Cell Biochem. 2018 Jun;119(6):4304-4308. doi: 10.1002/jcb.26786. Epub 2018 Feb 26. Review.

PMID:
29479734
43.

Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factors.

Stratigou T, Dalamaga M, Antonakos G, Marinou I, Vogiatzakis E, Christodoulatos GS, Karampela I, Papavassiliou AG.

Endocrine. 2018 Jul;61(1):83-93. doi: 10.1007/s12020-018-1550-3. Epub 2018 Feb 17.

PMID:
29455364
44.

The influence of delayed cord clamping and cord milking on inflammatory cytokines in umbilical vein and neonatal circulation.

Daskalakis G, Papapanagiotou A, Siristatidis C, Drakakis P, Mole I, Barbouni A, Papavassiliou AG, Pergialiotis V.

Acta Obstet Gynecol Scand. 2018 May;97(5):624-628. doi: 10.1111/aogs.13294. Epub 2018 Feb 8.

PMID:
29338067
45.

Prognostic significance of arterial stiffness and osteoprotegerin in patients with stable coronary artery disease.

Siasos G, Oikonomou E, Maniatis K, Georgiopoulos G, Kokkou E, Tsigkou V, Zaromitidou M, Antonopoulos A, Vavuranakis M, Stefanadis C, Papavassiliou AG, Tousoulis D.

Eur J Clin Invest. 2018 Mar;48(3). doi: 10.1111/eci.12890. Epub 2018 Jan 29.

PMID:
29330911
46.

Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?

Kollia C, Antonopoulos AS, Siasos G, Konsola T, Oikonomou E, Gouliopoulos N, Tsigkou V, Papapanagiotou A, Kassi E, Tentolouris N, Katsiki N, Vavuranakis M, Papavassiliou AG, Tousoulis D.

Curr Vasc Pharmacol. 2019;17(2):204-208. doi: 10.2174/1570161116666180108113825.

PMID:
29308741
47.

Polycystins and mechanotransduction in bone.

Gargalionis AN, Basdra EK, Papavassiliou AG.

Oncotarget. 2017 Nov 13;8(63):106159-106160. doi: 10.18632/oncotarget.22421. eCollection 2017 Dec 5. No abstract available.

48.

Cancer mechanobiology: Effects and therapeutic perspectives.

Gargalionis AN, Basdra EK, Papavassiliou AG.

Int J Cancer. 2018 Apr 1;142(7):1298-1299. doi: 10.1002/ijc.31221. Epub 2017 Dec 29. No abstract available.

49.

Mechanosignalling in tumour progression.

Gargalionis AN, Basdra EK, Papavassiliou AG.

J Cell Mol Med. 2018 Feb;22(2):704-705. doi: 10.1111/jcmm.13452. Epub 2017 Nov 14. No abstract available.

50.

Epigenetic Pathways Offer Targets for Ovarian Cancer Treatment.

Gyparaki MT, Papavassiliou AG.

Clin Breast Cancer. 2018 Jun;18(3):189-191. doi: 10.1016/j.clbc.2017.09.009. Epub 2017 Sep 19. Review. No abstract available.

PMID:
29042129

Supplemental Content

Loading ...
Support Center